AEPCX
Price
$59.73
Change
-$0.15 (-0.25%)
Updated
Jul 2 closing price
Net Assets
143.2B
AFCNX
Price
$19.09
Change
-$0.05 (-0.26%)
Updated
Jul 2 closing price
Net Assets
201.93M
Interact to see
Advertisement

AEPCX vs AFCNX

AEPCX vs AFCNX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. AFCNX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and AFCNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 143B vs. AFCNX (202M). AEPCX pays higher dividends than AFCNX: AEPCX (2.11) vs AFCNX (0.02). AEPCX was incepted earlier than AFCNX: AEPCX (25 years) vs AFCNX (10 years). AEPCX (1.58) is less costly to investors than AFCNX (1.10). AFCNX is a more actively managed with annual turnover of: 90.00 vs. AEPCX (50.00). AEPCX has a lower initial minimum investment than AFCNX: AEPCX (250) vs AFCNX (2500). AEPCX annual gain was more profitable for investors over the last year : 5.43 vs. AFCNX (2.66). AFCNX return over 5 years is better than : -6.02 vs. AEPCX (-8.77).
AEPCXAFCNXAEPCX / AFCNX
Total Expense Ratio1.581.10144%
Annual Report Gross Expense Ratio1.581.10144%
Fund Existence25 years10 years-
Gain YTD3.3930.580585%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets143B202M70,792%
Annual Yield % from dividends2.110.0210,331%
Returns for 1 year5.432.66204%
Returns for 3 years17.8419.7790%
Returns for 5 years-8.77-6.02146%
Returns for 10 years44.8097.4946%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LKBAX28.560.28
+0.99%
LKCM Balanced
CDVZX20.780.08
+0.39%
Columbia Intrinsic Value Institutional
PEXMX40.94-0.23
-0.56%
T. Rowe Price Extended Equity Market Idx
LRSFX17.24-0.13
-0.75%
Lord Abbett Small Cap Value F
VMGIX118.48-1.06
-0.89%
Vanguard Mid-Cap Growth Index Investor